Quantcast

Latest heart transplant Stories

2008-08-29 03:00:03

WASHINGTON - Government regulators on Wednesday cleared the way for broader use of a blood test that can spare heart transplant patients the ordeal of repeated biopsies to check whether their bodies are rejecting the new organ. The Food and Drug Administration said the test, called AlloMap, is an example of how the science of genetics is changing the practice of medicine. The test analyzes certain kinds of genetic information contained in white blood cells. These are the cells that...

09f519a185cc9e6c44bd150cbfce5fe01
2008-08-28 13:00:00

On Wednesday, government regulators cleared the way for broader use of a blood test that can spare heart transplant patients the ordeal of repeated biopsies to check if their bodies are rejecting the new organ. The test, called AlloMap, is an example of how the science of genetics is changing the practice of medicine, the Food and Drug Administration said. Certain kinds of genetic information contained in white blood cells are analyzed in the test, including cells that help the body fight off...

2008-08-28 06:00:25

US-based molecular diagnostics company XDx has received market clearance from the FDA for AlloMap molecular expression testing. According to the company, the AlloMap test is a noninvasive, multi-gene molecular diagnostics blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate or severe acute cellular rejection at the time of testing, in conjunction with standard clinical assessment. AlloMap testing...

2008-08-27 12:00:34

The U.S. Food and Drug Administration has approved a non-invasive molecular test to aid doctors in managing heart transplant patients after surgery. The newly approved molecular expression test, called "AlloMap,""can help contribute to an appropriate treatment plan by identifying those patients not experiencing post-operative heart transplant rejection," said Dr. Daniel Schultz, director of the FDA's Center for Devices and Radiological Health. "It is an example of how advancements in...

2008-08-27 06:00:20

XDx, Inc. has received market clearance from the U.S. Food and Drug Administration (FDA) for AlloMap(R) Molecular Expression Testing. The AlloMap Test is a noninvasive, multi-gene molecular diagnostics blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing, in conjunction with standard clinical assessment. XDx is the first U.S. molecular diagnostics...

2008-07-17 09:01:20

On July 10, the Penn State Hershey Heart and Vascular Institute's Mechanical Circulatory Support Team performed its first 2008 implant of the CardioWest(TM) temporary Total Artificial Heart on a 57-year-old male patient. The Medical Center implanted its first CardioWest artificial heart in May 2007 as a bridge to human heart transplant. The latest implant follows the recent arrival of Dr. Aly El-Banayosy, the new Director of the Penn State Hershey Heart and Vascular Institute's Intensive Care...

2008-06-30 15:03:02

By Glen Eller, McAlester News-Capital, Okla. Jun. 30--BY GLEN ELLER SPORTS EDITOR Evelyn Lienhard never thought she would celebrate her 50th wedding anniversary with her husband James. The Lienhards had been married for nearly 34 years when they found out that James' heart was failing. He was suffering from cardiomyopathy. His heart muscle was dying. He needed another heart. On April 15, 1992, a date the couple will always remember, they received the most precious gift -- a...

2007-08-16 06:16:41

By Stewart, Susan Context.-Pulmonary infections are common and often life- threatening in solid organ and stem cell transplant recipients. Understanding their pathology is critical to making improvements in care and survival as well as in surgical techniques, immunosuppression management, prophylaxis, and treatment. Pulmonary infections are particularly common and serious in the susceptible population of lung transplant recipients. Objective.-To summarize recent updates in the field for...

2007-06-19 06:00:12

By McCalmont, Vicki Bennett, Kristi Progressive multifocal leukoencephalopathy is a rare, highly fatal demyelinating brain infection caused by the JC virus. This infection is associated with immunosuppressive agents and is emerging in the transplant population. There has never been a documented case of progressive multifocal leukoencephalopathy in a transplant recipient receiving sirolimus. We present a study, in which the JC virus was found in a 68-year-old man who had received a...

2006-02-10 15:30:28

SAN FRANCISCO (Reuters) - Norman Shumway, who performed the first U.S. heart transplant, died on Friday a day after his 83rd birthday from complications related to cancer, Stanford University announced. South African Christiaan Barnard performed the world's first human heart transplant in Cape Town in December 1967, but the patient lived for only 18 days. Shumway undertook the first U.S. heart transplant the next year. Most early heart transplant patients did not live long, as their...


Latest heart transplant Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »
Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.